Ying‐Tzu Chang
ORCID: 0009-0007-9913-1041
· 1 paper in corpus
Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MD…